A recent phase three program showed it improved A1C (a three-month average of blood sugar) more than comparators [the drugs it was tested against] and led to significant weight loss, with side effects mostly in the digestive tract (nausea, vomiting [and] diarrhea), like other GLP-1 drugs. Wegovy pill Orforglipron isnt the only pill-form GLP-1 generating excitement
It helps to maintain results
Patients should contact their healthcare provider promptly for severe or persistent abdominal pain (possible pancreatitis or gallbladder disease), signs of dehydration from vomiting or diarrhea, marked hyperglycemia, or new/worsening vision changes
Clinical Applications Flanagan et al
A: This product is formulated for intravenous (IV), intramuscular (IM), subcutaneous (SC), and intradermal (ID) administration routes